NUGL.AI — Age Verification Required

NUGL.AI contains content related to cannabis, psychedelics, and cryptocurrency. You must be of legal age to enter.

NUGL.AI Beta Launch — Explore our beta platform and discover AI-powered cannabis intelligence, marketplace tools, and investor insights.

By entering, you confirm that you are of legal age in your jurisdiction to view cannabis and psychedelics-related content.

Verification remembered for 30 days. Educational purposes. 18+ (21+ in certain regions).

NUGL
VERIFIED · CONSCIOUS · GLOBAL

PsychedelicsHub.

"The verified global directory for psychedelic companies, retreat centers, research, therapy, and SPORZ® products."

Official Wellness Partner

Featured Wellness Partner

Powered by Choose Happy

Find your happiness. Jamaica-born wellness products designed to elevate mind, body, and mood.

Official Wellness Partner of NUGL.AI

50+

Verified Listings

15

Featured Partners

6

Categories

Conscious

Community

Browse by category

Monetize with Psychedelics Hub

Get discovered. Get featured. Get buyers.

Reach the fastest-growing psychedelics audience — retreat operators, therapy seekers, research partners, and SPORZ® product buyers. Verified directory placement & brand partnerships.

Verified audience|Premium inventory|Sponsor placements

Listing

$9.99/mo

Verified badge · search visibility · category discovery.

Most Popular

Featured

$19.99/mo

Priority placement · top of category · 5 images & lead button.

Premium

$49.99/mo

Homepage spotlight · sponsorship block · monthly performance email.

Top Companies

Leading biotech and research companies advancing psychedelic medicine

COMPASS Pathways
#1
Featured

COMPASS Pathways

Since 2016

9.8/10
Biotech - Psilocybin

Focus

Treatment-resistant depression therapy

Key Metrics

Phase III trials, COMP360 psilocybin therapy

MindMed
#2
Featured

MindMed

Since 2019

9.6/10
Biotech - LSD/MDMA

Focus

Major depressive disorder, ADHD, anxiety

Key Metrics

First public psychedelic company, MM120 trials

MAPS
#3
Featured

MAPS

Since 1986

9.8/10
Research - MDMA

Focus

MDMA-assisted therapy for PTSD

Key Metrics

Leading PTSD research, clinical trial breakthroughs

Cybin Inc.
#4
Featured

Cybin Inc.

Since 2019

9.3/10
Biotech - Psilocybin/DMT

Focus

Depression and anxiety treatments

Key Metrics

Phase 2 trials, strong IP portfolio

GH Research
#5
Featured

GH Research

Since 2018

9.1/10
Biotech - 5-MeO-DMT

Focus

Treatment-resistant depression

Key Metrics

Phase 2b trials, rapid antidepressant effects

Atai Life Sciences
#6
Featured

Atai Life Sciences

Since 2018

9.3/10
Biotech - Multi-compound

Focus

Mental health disorders

Key Metrics

Broad pipeline, multiple psychedelic therapies

Numinus Wellness
#7
Featured

Numinus Wellness

Since 2018

8.9/10
Clinics & Research

Focus

Psychedelic-assisted psychotherapy

Key Metrics

Licensed clinics, clinical research network

Field Trip Health
#8

Field Trip Health

Since 2019

8.8/10
Clinics & Research

Focus

Ketamine therapy and psilocybin research

Key Metrics

Legal research facility in Jamaica

Small Pharma
#9

Small Pharma

Since 2015

8.6/10
Biotech - DMT

Focus

Depression treatment with short-acting DMT

Key Metrics

Rapid-acting psychedelic formulation

Awakn Life Sciences
#10
Featured

Awakn Life Sciences

Since 2020

8.7/10
Clinics & Research

Focus

Addiction treatment with psychedelics

Key Metrics

UK-based clinics, ketamine therapy

About Psychedelics Hub

The Psychedelics Hub showcases the leading organizations in the rapidly growing field of psychedelic medicine. From groundbreaking research to therapeutic applications, these companies and institutions are shaping the future of mental health treatment.

Verified Ratings

Combined scores from multiple data points

Industry Leaders

Top-performing organizations worldwide

Evidence-Based

Research-backed rankings and analysis